FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18066311000001107: Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62188101000001116 Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62188201000001111 Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has specific active ingredient Aliskiren hemifumarate true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Is a Aliskiren 300mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has AMP Rasilez 300mg tablets (Lexon (UK) Ltd) true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has specific active ingredient Aliskiren hemifumarate false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Aliskiren false Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rasilez 300mg tablets (Lexon (UK) Ltd) 28 tablet Has basis of strength substance Aliskiren true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start